The small leucine‐rich repeat proteoglycans in tissue repair and atherosclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|278|5|447-461

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.278, Iss.5, 2015-11, pp. : 447-461

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brief Report: Distinct Dysregulation of the Small Leucine‐Rich Repeat Protein Family in Osteoarthritic Acetabular Labrum Compared to Articular Cartilage

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 2, 2015-02 ,pp. : 435-441

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ten Years and Counting: Moving Leucine‐Rich RepeatKinase 2 Inhibitors to the Clinic

By  

MOVEMENT DISORDERS, Vol. 30, Iss. 2, 2015-02 ,pp. : 180-189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leucine rich repeat kinase knockout (LRRK KO) mouse model: Linking pathological hallmarks of inherited and sporadic Parkinson's disease

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 1, 2018-01 ,pp. : 72-72

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in these patients

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 1, 2015-10 ,pp. : 35-44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers

By  

MOVEMENT DISORDERS, Vol. 33, Iss. 2, 2018-02 ,pp. : 335-338

John Wiley & Sons Inc

Access to resources Recommend Favorite